TrialCancer research and treatment2026
Neoadjuvant Sintilimab Combined with Gemcitabine and Cisplatin for Muscle-Invasive Bladder Cancer Patients Followed by Selective Bladder Sparing Surgery: A Phase 2 Trial.
Zhou Tong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.